Simultaneous Fluorescent Monitoring of Proteasomal Subunit Catalysis
- 15 January 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 132 (5), 1578-1582
- https://doi.org/10.1021/ja907226n
Abstract
The proteasome, a multicatalytic protease, displays distinct chymotrypsin-like, caspase-like, and trypsin-like activities at three different subunits of the multimeric complex. Fluorescent substrates for each of these active sites have been described. However, since the fluorescent properties of these substrates are very similar, it is not possible to simultaneously monitor catalysis of two or more activities. We have developed a long wavelength (λex = 600 nm, λem = 700 nm) fluorescent substrate for the chymotrypsin-like active site via a combinatorial library strategy. This peptide-based substrate is a highly selective proteasomal chymotrypsin-like sensor, as assessed by a series of proteasomal active site mutants in yeast cell lysates. A corresponding caged analog of the sensor has been prepared, which is resistant to proteolysis until activated by 349 nm light. The latter affords the opportunity to assess proteasomal activity with a high degree of temporal control. The distinct photophysical properties of the sensor allow the chymotrypsin-like activity to be simultaneously monitored during caspase-like or trypsin-like catalysis. We have found that chymotrypsin-like activity is enhanced in the presence of the trypsin-like substrate but reduced in the presence of caspase-like substrate. Furthermore, the chymotrypsin-like sensor hinders the activity of both the caspase- and trypsin-like active sites. Coincident monitoring of two catalytic active sites furnishes two-thirds coverage of total proteasomal activity, which should provide the means to address if and how the distinct active sites of the proteasome influence one another during catalysis.Keywords
This publication has 20 references indexed in Scilit:
- Clinical development of novel proteasome inhibitors for cancer treatmentExpert Opinion on Investigational Drugs, 2009
- Catalytic Mechanism and Assembly of the ProteasomeChemical Reviews, 2009
- Is the focus moving toward a combination of targeted drugs?Best Practice & Research Clinical Haematology, 2008
- Monitoring Activity and Inhibition of 26S Proteasomes with Fluorogenic Peptide SubstratesMethods in enzymology, 2005
- Extended peptide-based inhibitors efficiently target the proteasome and reveal overlapping specificities of the catalytic β-subunitsCell Chemical Biology, 2001
- The Human 26 S and 20 S Proteasomes Generate Overlapping but Different Sets of Peptide Fragments from a Model Protein SubstratePublished by Elsevier BV ,2000
- Evidence for the Existence of a Non-catalytic Modifier Site of Peptide Hydrolysis by the 20 S ProteasomePublished by Elsevier BV ,2000
- Proteasome Active Sites Allosterically Regulate Each Other, Suggesting a Cyclical Bite-Chew Mechanism for Protein BreakdownMolecular Cell, 1999
- Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolase 1Proceedings of the National Academy of Sciences of the United States of America, 1998
- Regulation of the peptidylglutamyl-peptide hydrolyzing activity of the pituitary multicatalytic proteinase complexBiochemistry, 1991